D Hexsel
Overview
Explore the profile of D Hexsel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hexsel D, Hexsel C, Mosena G, Dos Santos A, Fabris V
J Eur Acad Dermatol Venereol
. 2023 Apr;
PMID: 37102361
No abstract available.
2.
Hexsel D, Hexsel C, Porto M, Siega C
J Eur Acad Dermatol Venereol
. 2014 Apr;
29(1):128-33.
PMID: 24684165
Background: Post-inflammatory hyperpigmentation is a frequent concern when treating solar lentigines. Objectives: To assess the safety and efficacy of a triple combination cream with fluocinolone acetonide 0.01%, hydroquinone 4% and...
3.
Arellano I, Cestari T, Ocampo-Candiani J, Azulay-Abulafia L, Bezerra Trindade Neto P, Hexsel D, et al.
J Eur Acad Dermatol Venereol
. 2011 Jun;
26(5):611-8.
PMID: 21623930
Background: The relapsing nature of melasma emphasizes the need to maintain efficacy achieved after acute treatment. Objective: To compare clinical efficacy and safety of two 6-month Triple Combination (TC; containing...
4.
Ascher B, Talarico S, Cassuto D, Escobar S, Hexsel D, Jaen P, et al.
J Eur Acad Dermatol Venereol
. 2010 Jun;
24(11):1285-95.
PMID: 20569284
Background: Azzalure® (Galderma SA), a newly approved European botulinum neurotoxin type A (BoNT-A), is derived from Dysport™ (Ipsen Ltd.), which has a 20-year history of product consistency and has been...
5.
Ascher B, Talarico S, Cassuto D, Escobar S, Hexsel D, Jaen P, et al.
J Eur Acad Dermatol Venereol
. 2010 Mar;
24(11):1278-84.
PMID: 20337830
Background: Azzalure (Galderma SA) is a newly approved European botulinum neurotoxin type A (BoNT-A). It is derived from Dysport (Ipsen Pharma), which has a long history of usages in various...
6.
Cestari T, Arellano I, Hexsel D, Ortonne J
J Eur Acad Dermatol Venereol
. 2009 Aug;
23(7):760-72.
PMID: 19646135
Objective/aim: To examine approaches to therapy for melasma in Latin Americans and to propose treatment algorithms for patients with mild, moderate and severe melasma. Background: Melasma is prevalent in up...
7.
Ortonne J, Arellano I, Berneburg M, Cestari T, Chan H, Grimes P, et al.
J Eur Acad Dermatol Venereol
. 2009 Jun;
23(11):1254-62.
PMID: 19486232
Background: It has been generally believed that the four main causes of melasma are pregnancy, hormonal contraception, family history and sun exposure; however, there are few published comprehensive studies that...
8.
Hexsel D, Rodrigues T, Dalforno T, Zechmeister-Prado D, Lima M
J Eur Acad Dermatol Venereol
. 2008 Jul;
23(3):367-8.
PMID: 18631207
No abstract available.
9.
Cestari T, Hexsel D, Viegas M, Azulay L, Hassun K, Almeida A, et al.
Br J Dermatol
. 2006 Dec;
156 Suppl 1:13-20.
PMID: 17176300
Background: Pigmentation disorders, such as melasma, greatly influence the quality of life (QoL) of affected individuals who usually consider the disorder to be more severe than the objective clinical scores....
10.
Hexsel D, Arellano I, Rendon M
Br J Dermatol
. 2006 Dec;
156 Suppl 1:7-12.
PMID: 17176299
Latin-Americans have a heterogeneous ancestry that is defined by their place of domicile, while Hispanics are defined as those persons of Spanish descent. These two groups have a diverse range...